In 1997, we published a review in Pharmaco Economics about quality of life (QOL)
measurement in patients with schizophrenia. The objective of this article is to provide an …

Hypofunction of the N-methyl-d-aspartate receptor (NMDAR) has been implicated in the
pathophysiology of schizophrenia. The NMDAR contains a d-serine/glycine site on the NR1 …

Background People with mental illness (PWMI) have declining health related quality of life
(HRQoL), which is frequently equivalent to or greater than that of medical disorders …

Goals The aim of this study was to explore the quality of life, self-stigma, personality traits,
and hope in patients with schizophrenia spectrum disorders. Patients and methods A total of …

Clinical concepts of mental illness have always been modulated by underlying theoretical
considerations. For the past fifty years, schizophrenia has been considered primarily a …

Abstract Background Quality of life (QoL) is considered an important outcome in health
research. It can be rated by the patient, or by an external assessor. We wished to identify the …

Objective Psychosocial dysfunction was a nettlesome problem of schizophrenia even in their
prodromal phase as well as in their first-episode. In addition, its relations with …

The author reviewed measurement of quality of life (QOL) of schizophrenia patients and the
clinical factors related to their QOL. As schizophrenia patients were thought to be unable to …

Studies on unmet needs during the last decades have played a significant role in the
development and dissemination of evidence-based community practices for persistent …

The main purpose of the present study was to examine the relationship between quality of
life (QOL) and cognitive dysfunction in schizophrenia. Subjects were 61 stabilized …